Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Plane, Trains…and Drones? How to Catch Your Target Audience on the Go

    White Papers and Resources | December 4, 2024 | CMI Media Group

    Global airfare is consistently increasing year-over-year (2020 being quite the exception), with this year trending to set a new record of 40.1 million flights in 2024.

    Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online

    Press Releases | December 3, 2024 | Genesis Research Group

    Genesis Research Group's poster 'Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey' was recently named as...

    FAQs about systematic literature reviews and network meta-analyses in healthcare

    White Papers and Resources | December 3, 2024 | Petauri Evidence

    Are you new to the world of evidence synthesis for market access? Are you unsure about some of the terminology used by specialists who are preparing your evidence dossier? Here,...

    Highlighting the Power of Patient-Integration

    Press Releases | December 2, 2024 | Medscape Education

    Advancing person-centered care is an important topic for the Medscape Oncology team, and no one knows this better than Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy for Medscape Oncology...

    Seven strategic steps to enhance patient recruitment & retention in your influenza studies

    White Papers and Resources | November 29, 2024 | Innovative Trials

    The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

    Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

    White Papers and Resources | November 26, 2024 | Genesis Research Group

    A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

    Education, AI and More at ASH 2024

    Press Releases | November 25, 2024 | Medscape Education

    Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year's programs,...

    Innovative Trials celebrates success for its groundbreaking Retention Patch Program

    Press Releases | November 22, 2024 | Innovative Trials

    Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

    Genesis Research Group unveils enhanced US market access data analytics

    Press Releases | November 21, 2024 | Genesis Research Group

    Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

    Stacking the odds in your favour with landscape analysis

    White Papers and Resources | November 21, 2024 | Amiculum

    By James Aird and Jess Choi